Ionis Pharmaceuticals, Inc.
MODULATION OF LNC05 EXPRESSION
Last updated:
Abstract:
Provided herein are methods, compounds, and compositions for reducing expression of lnc05 in a cell or individual. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate a cancer in an individual.
Status:
Application
Type:
Utility
Filling date:
3 Jun 2021
Issue date:
23 Sep 2021